Biotech Counts in Cambridge

After working as a research fellow for nearly seven years at the University of California, San Francisco, Alex Duncan wanted to settle down and raise a family. Rather than stay in the United States, he decided to put down roots in Cambridge, England. The decision wasn't difficult, since both he and his wife were from the United Kingdom, and he had done graduate work at the Medical Research Council (MRC) Laboratory of Molecular Biology in Cambridge. "Cambridge is a vibrant university town with a

| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

"Cambridge is a vibrant university town with an academic atmosphere that's very collegial," says Duncan, vice president for drug discovery at Cambridge Antibody Technology (CAT), a spin-off company founded 12 years ago using MRC research. "It's a beautiful place to live with lots of bright, interesting people around--not just scientists, but people in economics, business, history, and the arts. The area is just booming."

Bursting at the seams might be a more apt description. Cambridge is a biotechnology powerhouse where centuries of academic excellence--dating from before Sir Isaac Newton--come face to face with the largest and fastest growing concentration of life sciences companies and research institutions in Britain. "Cambridge has a creative, inventive environment, especially in the biosciences, because of its extremely strong academic background," says Tony Talbot, chief executive of Iceni BioDiscovery, a 13-person start-up company developing cell transplantation therapies for diabetes and other diseases. "It attracts very high-quality, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Ted Agres

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo